85 related articles for article (PubMed ID: 10779803)
21. Characterization of drug-specific T cells in phenobarbital-induced eruption.
Hashizume H; Takigawa M; Tokura Y
J Immunol; 2002 May; 168(10):5359-68. PubMed ID: 11994495
[TBL] [Abstract][Full Text] [Related]
22. Purification of Ag-specific T lymphocytes after direct peripheral blood mononuclear cell stimulation followed by CD25 selection. I. Application to CD4(+) or CD8(+) cytomegalovirus phosphoprotein pp65 epitope determination.
Gallot G; Vivien R; Ibisch C; Lulé J; Davrinche C; Gaschet J; Vié H
J Immunol; 2001 Oct; 167(8):4196-206. PubMed ID: 11591740
[TBL] [Abstract][Full Text] [Related]
23. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
24. A NK1.1+ thymocyte-derived TCR beta-chain transgene promotes positive selection of thymic NK1.1+ alpha beta T cells.
Viret C; Lantz O; He X; Bendelac A; Janeway CA
J Immunol; 2000 Sep; 165(6):3004-14. PubMed ID: 10975809
[TBL] [Abstract][Full Text] [Related]
25. Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus.
Bitmansour AD; Waldrop SL; Pitcher CJ; Khatamzas E; Kern F; Maino VC; Picker LJ
J Immunol; 2001 Aug; 167(3):1151-63. PubMed ID: 11466329
[TBL] [Abstract][Full Text] [Related]
26. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
[TBL] [Abstract][Full Text] [Related]
27. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
[TBL] [Abstract][Full Text] [Related]
28. Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.
Gallot G; Vollant S; Vivien R; Clémenceau B; Ferrand C; Tiberghien P; Gaschet J; Robillard N; Vié H
Clin Exp Immunol; 2006 Apr; 144(1):158-68. PubMed ID: 16542378
[TBL] [Abstract][Full Text] [Related]
29. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS
J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869
[TBL] [Abstract][Full Text] [Related]
30. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
[TBL] [Abstract][Full Text] [Related]
31. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.
Argaet VP; Schmidt CW; Burrows SR; Silins SL; Kurilla MG; Doolan DL; Suhrbier A; Moss DJ; Kieff E; Sculley TB; Misko IS
J Exp Med; 1994 Dec; 180(6):2335-40. PubMed ID: 7964506
[TBL] [Abstract][Full Text] [Related]
32. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
[TBL] [Abstract][Full Text] [Related]
33. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
34. Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1.
Marshall NA; Vickers MA; Barker RN
J Immunol; 2003 Jun; 170(12):6183-9. PubMed ID: 12794149
[TBL] [Abstract][Full Text] [Related]
35. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones.
Edinger JW; Bonneville M; Scotet E; Houssaint E; Schumacher HR; Posnett DN
J Immunol; 1999 Mar; 162(6):3694-701. PubMed ID: 10092832
[TBL] [Abstract][Full Text] [Related]
36. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
[TBL] [Abstract][Full Text] [Related]
37. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.
de la Salle H; Houssaint E; Peyrat MA; Arnold D; Salamero J; Pinczon D; Stevanovic S; Bausinger H; Fricker D; Gomard E; Biddison W; Lehner P; UytdeHaag F; Sasportes M; Donato L; Rammensee HG; Cazenave JP; Hanau D; Tongio MM; Bonneville M
J Immunol; 1997 May; 158(10):4555-63. PubMed ID: 9144467
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
39. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
[TBL] [Abstract][Full Text] [Related]
40. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
